Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk
EuroIntervention · 2024-03 · 20 (5) · e281-e288
DOI: 10.4244/eij-d-23-00734 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuroIntervention, 2024-03. Verfasst von Johannes A Ziegelmueller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, Muni…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Surgeons, Mitral Valve Stenosis, Mitral Valve Insufficiency. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Data comparing transcatheter mitral valve implantation (TMVI) with surgical mitral valve replacement (SMVR) are lacking. AIMS: This study sought to compare the 30-day Valve Academic Research Consortium (VARC)-3 device success of TMVI with that of SMVR. METHODS: Matching protocol combined exact matching (sex, atrial fibrillation, previous surgical aortic valve replacement [SAVR] or coronary artery bypass grafting [CABG]), coarsened exact matching (age) and propensity score matching (body mass index, mitral valve pathology and concomitant tricuspid regurgitation). RESULTS: A total of 40 Tendyne TMVI and 80 SMVR patients with similar baseline characteristics were analysed (TMVI vs SMVR): age (78 years [interquartile range [{IQR} 75; 80] vs 78 years [IQR 73; 80]; p=0.8), female (60% vs 60%; p=1.0), atrial fibrillation (67.5% vs 63.7%; p=0.8), previous SAVR (12.5% vs 10.0%; p=0.8), previous CABG (20.0% vs 16.2%; p=0.8), body mass index (25.54 kg/m² vs 25.24 kg/m²; p=0.7) and valve pathology (mitral regurgitation: 70.0% vs 73.8%, mitral stenosis: 7.5% vs 3.8%, and mixed disease: 22.5% vs 22.5%; p=0.6). Most baseline characteristics not included in the matching model were balanced among the TMVI/SMVR cohorts: European System for Cardiac Operative Risk Evaluation (EuroSCORE) II (5.8% [IQR 2.9; 7.5] vs 4.2% [IQR 2.4; 6.8]; p=0.3) and Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score (5.2% [IQR 3.2; 8.6] vs 4.1% [IQR 3.3; 6.1]; p=0.076). Coronary artery disease (67.5% vs 32.5%; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, Munich, Germany.
- Institute of Anaesthesiology, German Heart Center Munich, School of Medicine & Health, Technical University Munich, Munich, Germany.
- Yale School of Medicine, Division of Cardiac Surgery, Department of Surgery, New Haven, CT, USA.
Zitieren
APA
Ziegelmueller, J. A., Burri, M., Stein, A., Tassani-Prell, P., Krane, M., Lange, R., & Ruge, H. (2024). Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk. EuroIntervention, 20(5), e281-e288. https://doi.org/10.4244/eij-d-23-00734
Vancouver
Ziegelmueller JA, Burri M, Stein A, Tassani-Prell P, Krane M, Lange R, et al. Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk. EuroIntervention. 2024;20(5):e281-e288. doi:10.4244/eij-d-23-00734
BibTeX
@article{Ziegelmueller2024,
author = {Ziegelmueller, Johannes A and Burri, Melchior and Stein, Andreas and Tassani-Prell, Peter and Krane, Markus and Lange, Rüdiger and Ruge, Hendrik},
title = {Early outcomes of transapical mitral valve implantation versus surgical replacement in matched elderly patients at intermediate surgical risk},
journal = {EuroIntervention},
year = {2024},
volume = {20},
number = {5},
pages = {e281--e288},
doi = {10.4244/eij-d-23-00734}
}
EUVIMED